Skip to main content
Swing Capital

Valiant Organics Ltd

NSE: VALIANTORG BSE: 540145Pharma

Incorporated in 1984, Valiant Organics Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]

₹297
52W: ₹195 — ₹508
PE 27.5 · Book ₹249 · +19% vs book
Market Cap₹832 Cr
Stock P/E27.5Price to Earnings
ROCE6.21%Return on Capital
ROE4.44%Return on Equity
Div. Yield0%Face Value ₹10

Weaknesses

  • −The company has delivered a poor sales growth of 5.16% over past five years.
  • −Company has a low return on equity of 0.97% over last 3 years.

Shareholding Pattern

Promoters37.89%
FIIs0.28%
DIIs0%
Public61.82%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters37.77%37.77%37.73%▼0.037.91%▲0.237.91%37.91%37.89%▼0.037.89%
FIIs1.35%1.34%▼0.00.82%▼0.50.37%▼0.40.21%▼0.20.21%0.22%▲0.00.28%▲0.1
DIIs0.09%0.08%▼0.00%▼0.10%0%0%0%0%
Public60.79%60.8%▲0.061.44%▲0.661.72%▲0.361.87%▲0.161.86%▼0.061.89%▲0.061.82%▼0.1

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales141177168160187204204157159218
Expenses138179152158172183180136143191
Operating Profit4-2162152125211626
OPM %3%-1%9%1%8%10%12%13%10%12%
Net Profit-7-110-115486615
EPS ₹-2.43-3.86-0.16-4.041.681.412.7122.165.4

AI Insights

Revenue Trend

Mar 2026 revenue at ₹738Cr, up 2.6% YoY. OPM at 12%.

Debt Position

Borrowings at ₹219Cr. Debt-to-equity ratio: 0.33x. Healthy balance sheet.

Capex Cycle

CWIP at ₹21Cr (3% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0% (-0.88pp change). FIIs: 0.28% (-0.02pp change). Promoters hold 37.89%.

Margin & Efficiency

ROCE declining from 43% (Mar 2015) to 6% (Mar 2026). Working capital days: 18.

Valuation

PE 27.5x with 6.21% ROCE. Price is 19% above book value of ₹249. Dividend yield: 0%.

Recent Announcements